Display Settings:

Format

Send to:

Choose Destination
    Haematologica. 2011 Feb;96(2):323-7. Epub 2010 Nov 3.

    Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.

    Source

    Unit of Infections and Cancer (UNIC), IDIBELL, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain. dcasabonne@iconcologia.net

    Abstract

    Using EpiLymph case-control data, we found that chronic lymphocytic leukemia patients were more likely to have abnormal reactive serological patterns to Epstein Barr virus than controls. Here, we aimed to assess whether this association is modified by genetic variants. We examined 1,305 Single Nucleotide Polymorphisms from 300 selected genes related to various pathways in 240 cases and 513 controls from five European centers. In a recessive model, patients positive to aberrant antibody pattern and homozygous for rare genotypes in rs8113877T>G or rs17576A>G of the MMP9 gene were at highest risk of chronic lymphocytic leukemia. In a dominant model, TP73 showed the highest risk in patients positive to aberrant antibody pattern and homozygous for the wild-type genotype in rs1885859G>C or rs3765701A>T. All interactions were additive and no main effect was observed. The strong interactions observed may be indicative of a specific pathway in cancer genesis. Confirmation of these results is warranted.

    PMID:
    21048031
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3031703
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk